Team:Imperial College London/Project Chemotaxis Assembly
From 2011.igem.org
Line 11: | Line 11: | ||
</div> | </div> | ||
<br> | <br> | ||
- | <p>We ordered both the PA2652 coding sequencs as two fragments to minimise cost and time (fig. 1). We did not want to use PCR to amplify the fragments in order to avoid introducing mutations into our final construct, and so we engineered blunt end cut sites on either side of our synthesized sequences with the MlyI restriction enzyme. | + | <p>We ordered both the PA2652 coding sequencs as two fragments to minimise cost and time (fig. 1). We did not want to use PCR to amplify the fragments in order to avoid introducing mutations into our final construct, and so we engineered blunt end cut sites on either side of our synthesized sequences with the MlyI restriction enzyme. MlyI (type II restriction enzyme) cuts bluntly, 5 bp away from the recognition site. This property allowed us to cut out only the coding sequence of each fragment. Each digested fragment was then gel extracted to prepare for assembly.</p> |
<p>The pSB1C3 vector was simultaneously inverse PCR'd to amplify the backbone vector with the required overlaps. </p> | <p>The pSB1C3 vector was simultaneously inverse PCR'd to amplify the backbone vector with the required overlaps. </p> |
Revision as of 15:28, 21 September 2011
Module 1: Phyto-Route
Chemotaxis is the movement of bacteria based on attraction or repulsion of chemicals. Roots secrete a variety of compounds that E. coli are not attracted to naturally. Accordingly, we engineered a chemoreceptor into our chassis that can sense malate, a common root exudate, so that it can swim towards the root. Additionally, E. coli are actively taken up by plant roots, which will allow targeted IAA delivery into roots by our system.
Assembly
Fig. 1: Assembly strategy for our Phyto-Route construct.
We ordered both the PA2652 coding sequencs as two fragments to minimise cost and time (fig. 1). We did not want to use PCR to amplify the fragments in order to avoid introducing mutations into our final construct, and so we engineered blunt end cut sites on either side of our synthesized sequences with the MlyI restriction enzyme. MlyI (type II restriction enzyme) cuts bluntly, 5 bp away from the recognition site. This property allowed us to cut out only the coding sequence of each fragment. Each digested fragment was then gel extracted to prepare for assembly.
The pSB1C3 vector was simultaneously inverse PCR'd to amplify the backbone vector with the required overlaps.
We planned to combine the two fragments into the pSB1C3 vector by Gibson assembly, unfortunately our attempts failed, we postulate that this was due to homology on the backbone vector, causing it to re-anneal.
We reverted to CPEC to assemble the construct, a method that requires more extensive use of PCR than Gibson. This said, by introducing MlyI restrictin sites, we were able to halve the number of PCR steps required, thereby reducing the potential mutation rate.
CPEC (Circular Polymerase Extension Cloning) is a primer-independent PCR assembly technique which relies on overlaping sequences between each part to be assembled. With a denaturing step, the double stranded DNA is melted, allowing compatible single stranded ends of each part to joined. For this reason it is essential that the parts are designed with homologous ends (the fragments we used were designed with 60 bp overlaps). The annealed overlapping ends then serve as primers for polymerase extension to join the parts into a seamless construct.
DNA was mini-prepped from colonies and sequenced by Eurofins. The sequences came back positive so we could move on and start characterizing the PA2652 construct.
Fig 2. Schematic of the final construct. Click on the parts to be directed to the registry.
The second fragment of our codon optimised mcpS receptor has still not arrived and therefore could not be assembled. However Juan L. Ramos of Consejo Superior de Investigaciones Científicas in Spain was able to provide us with non-codon optimised mcpS gene with unknown promoter and ribosome binding site in the pRK415 vector. We have pereformed chemotaxis assays on this construct as well.